Evoke Pharma Stock Today
| EVOK Stock | USD 0.46 0.01 2.13% |
Performance0 of 100
| Odds Of DistressOver 84
|
Evoke Pharma is selling for 0.46 as of the 23rd of April 2024. This is a -2.13 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.46. Evoke Pharma has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Evoke Pharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of September 2013 | Category Healthcare | Classification Health Care |
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California. The company has 8.48 M outstanding shares of which 53.37 K shares are currently shorted by private and institutional investors with about 1.14 trading days to cover. More on Evoke Pharma
Moving against Evoke Stock
| 0.65 | DYAI | Dyadic International Financial Report 8th of May 2024 | PairCorr |
| 0.64 | ELYM | Eliem Therapeutics | PairCorr |
| 0.64 | ERNA | Eterna Therapeutics | PairCorr |
| 0.61 | OPT | Opthea | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Evoke Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Evoke Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Evoke Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO CoFounder | David RPh | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Evoke Pharma report their recommendations after researching Evoke Pharma's financial statements, talking to executives and customers, or listening in on Evoke Pharma's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Evoke Pharma. The Evoke consensus assessment is calculated by taking the average forecast from all of the analysts covering Evoke Pharma. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Evoke Pharma's financial statements, Evoke Pharma may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Evoke Pharma is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Evoke Pharma's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Evoke Pharma's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Evoke Pharma's financial leverage. It provides some insight into what part of Evoke Pharma's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Evoke Pharma (EVOK) is traded on NASDAQ Exchange in USA. It is located in 420 Stevens Avenue, Solana Beach, CA, United States, 92075 and employs 4 people. Evoke Pharma is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Evoke Pharma's market, we take the total number of its shares issued and multiply it by Evoke Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Evoke Pharma conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 8.48 M outstanding shares of which 53.37 K shares are currently shorted by private and institutional investors with about 1.14 trading days to cover.
Evoke Pharma currently holds about 13.45 M in cash with (4.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Evoke Pharma Probability Of Bankruptcy
Ownership AllocationEvoke Pharma retains a total of 8.48 Million outstanding shares. Evoke Pharma shows 9.64 percent of its outstanding shares held by insiders and 29.97699999999999 percent owned by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Evoke Ownership Details
Evoke Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of Evoke Pharma jumping above the current price in 90 days from now is close to 99%. The Evoke Pharma probability density function shows the probability of Evoke Pharma stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Evoke Pharma has a beta of -0.1568 suggesting as returns on the benchmark increase, returns on holding Evoke Pharma are expected to decrease at a much lower rate. During a bear market, however, Evoke Pharma is likely to outperform the market. Additionally, evoke Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Evoke Pharma to move above the current price in 90 days from now is close to 99 (This Evoke Pharma probability density function shows the probability of Evoke Stock to fall within a particular range of prices over 90 days) .
Evoke Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Evoke Pharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Evoke Pharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Evoke Pharma's value.| Instituion | Recorded On | Shares | |
| Vanguard Group Inc | 2023-12-31 | 29.9 K | |
| Geode Capital Management, Llc | 2023-12-31 | 27.1 K | |
| Tower Research Capital Llc | 2023-12-31 | 6.4 K | |
| Ubs Group Ag | 2023-12-31 | 2.9 K | |
| Blackrock Inc | 2023-12-31 | 1.5 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 375 | |
| Goss Wealth Management Llc | 2023-12-31 | 208 | |
| Royal Bank Of Canada | 2023-12-31 | 28.0 | |
| Wells Fargo & Co | 2023-12-31 | 26.0 | |
| Cwm, Llc Duplicate | 2023-12-31 | 16.0 | |
| Concord Wealth Partners | 2023-12-31 | 0.0 |
Evoke Pharma Historical Income Statement
Evoke Pharma Income Statement is one of the three primary financial statements used for reporting Evoke's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Evoke Pharma revenue and expense. Evoke Pharma Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Evoke Pharma's Interest Expense is quite stable compared to the past year. Selling General Administrative is expected to rise to about 11.6 M this year, although the value of Operating Income will most likely fall to (7.8 M). View More FundamentalsEvoke Stock Against Markets
Picking the right benchmark for Evoke Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Evoke Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Evoke Pharma is critical whether you are bullish or bearish towards Evoke Pharma at a given time. Please also check how Evoke Pharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Evoke Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
How to buy Evoke Stock?
Before investing in Evoke Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Evoke Pharma. To buy Evoke Pharma stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Evoke Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Evoke Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Evoke Pharma stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Evoke Pharma stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Evoke Pharma, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Evoke Stock please use our How to Invest in Evoke Pharma guide.
Already Invested in Evoke Pharma?
The danger of trading Evoke Pharma is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Evoke Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Evoke Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Evoke Pharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Evoke Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Evoke Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Evoke Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Evoke Pharma Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evoke Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Evoke Stock analysis
When running Evoke Pharma's price analysis, check to measure Evoke Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evoke Pharma is operating at the current time. Most of Evoke Pharma's value examination focuses on studying past and present price action to predict the probability of Evoke Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evoke Pharma's price. Additionally, you may evaluate how the addition of Evoke Pharma to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Evoke Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evoke Pharma. If investors know Evoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evoke Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.33) | Revenue Per Share 1.55 | Quarterly Revenue Growth 1.105 | Return On Assets (0.49) | Return On Equity (10.35) |
The market value of Evoke Pharma is measured differently than its book value, which is the value of Evoke that is recorded on the company's balance sheet. Investors also form their own opinion of Evoke Pharma's value that differs from its market value or its book value, called intrinsic value, which is Evoke Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evoke Pharma's market value can be influenced by many factors that don't directly affect Evoke Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evoke Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evoke Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evoke Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.